Amplyx Pharmaceuticals Secures $40,500,000 Series B Financing Round

  • Feed Type
  • Date
    11/11/2015
  • Company Name
    Amplyx Pharmaceuticals
  • Mailing Address
    3210 Merryfield Row San Diego, CA 92121 USA
  • Company Description
    Amplyx Pharmaceuticals is developing novel, broad-spectrum antifungal agents for the treatment of life-threatening fungal infections.
  • Website
    http://www.amplyx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $40,500,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Amplyx will use the funding to advance the clinical development of APX001, the company’s broad-spectrum antifungal agent to treat life threatening fungal infections.
  • M&A Terms
  • Venture Investor
    RiverVest Venture Partners
  • Venture Investor
    New Enterprise Associates
  • Venture Investor
    BioMed Ventures

Trending on Xconomy